HUP0301378A2 - Tiotropiumsót tartalmazó inhalációs oldatformájú gyógyszerkészítmény - Google Patents

Tiotropiumsót tartalmazó inhalációs oldatformájú gyógyszerkészítmény

Info

Publication number
HUP0301378A2
HUP0301378A2 HU0301378A HUP0301378A HUP0301378A2 HU P0301378 A2 HUP0301378 A2 HU P0301378A2 HU 0301378 A HU0301378 A HU 0301378A HU P0301378 A HUP0301378 A HU P0301378A HU P0301378 A2 HUP0301378 A2 HU P0301378A2
Authority
HU
Hungary
Prior art keywords
pharmacologically acceptable
pharmaceutical composition
composition containing
tiotropium salt
solution formulation
Prior art date
Application number
HU0301378A
Other languages
English (en)
Inventor
Petra Barth
Karin Drechsel
Barbara Niklaus-Humke
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of HUP0301378A2 publication Critical patent/HUP0301378A2/hu
Publication of HUP0301378A3 publication Critical patent/HUP0301378A3/hu
Publication of HU229411B1 publication Critical patent/HU229411B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgyát az alábbi összetevőkből álló gyógyszerkészítmény:- egy tiotropiumsó mint hatóanyag, aminek a tiotropiumban kifejezettkoncentrációja 0,0005 és 5 tömeg% között van, - víz vagy vizes etanol,mint a hatóanyag oldószere, - sav, a pH értékének 2,0 és 4,5 közé valóbeállítására, - egy farmakológiailag elfogadható konzerválószer, -adott esetben egy farmakológiailag elfogadható komplexképző és/vagystabilizátor és/vagy egy farmakológiailag elfogadható koszolvensés/vagy más farmakológiailag elfogadható segéd- és adalékanyagok, akonzerválószeren kívül; és főleg az asztma és/vagy a COPD kezelésérevaló alkalmazása képezi. Ó
HU0301378A 2000-10-31 2001-10-24 Inhalative solution formulation containing a tiotropium salt HU229411B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054036 2000-10-31
PCT/EP2001/012292 WO2002036104A2 (de) 2000-10-31 2001-10-24 Inhalative lösungsformulierung mit einem tiotropiumsalz

Publications (3)

Publication Number Publication Date
HUP0301378A2 true HUP0301378A2 (hu) 2003-10-28
HUP0301378A3 HUP0301378A3 (en) 2005-12-28
HU229411B1 HU229411B1 (en) 2013-12-30

Family

ID=7661723

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301378A HU229411B1 (en) 2000-10-31 2001-10-24 Inhalative solution formulation containing a tiotropium salt

Country Status (39)

Country Link
EP (2) EP1837021A3 (hu)
JP (1) JP4344135B2 (hu)
KR (1) KR100853107B1 (hu)
CN (2) CN101292964A (hu)
AR (1) AR038764A1 (hu)
AT (1) ATE373473T1 (hu)
AU (2) AU2002221738B2 (hu)
BG (1) BG66315B1 (hu)
BR (1) BRPI0115076B8 (hu)
CA (1) CA2426074C (hu)
CY (1) CY1107825T1 (hu)
CZ (1) CZ300794B6 (hu)
DE (2) DE50113037D1 (hu)
DK (1) DK1333819T3 (hu)
EA (1) EA007604B1 (hu)
EC (1) ECSP034541A (hu)
EE (1) EE05314B1 (hu)
ES (1) ES2294045T3 (hu)
HK (1) HK1060524A1 (hu)
HR (1) HRP20030338B1 (hu)
HU (1) HU229411B1 (hu)
IL (2) IL155538A0 (hu)
ME (1) ME00244B (hu)
MX (1) MXPA03003742A (hu)
MY (1) MY138940A (hu)
NO (1) NO332519B1 (hu)
NZ (1) NZ526023A (hu)
PE (1) PE20030092A1 (hu)
PL (1) PL203316B1 (hu)
PT (1) PT1333819E (hu)
RS (1) RS50859B (hu)
SA (1) SA01220482B1 (hu)
SI (1) SI1333819T1 (hu)
SK (1) SK286027B6 (hu)
TW (1) TWI293885B (hu)
UA (1) UA78690C2 (hu)
UY (1) UY26989A1 (hu)
WO (1) WO2002036104A2 (hu)
ZA (1) ZA200302922B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
WO2005042528A1 (de) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Neue tiotropiumsalze, verfahren zu deren herstellung sowie diese enthaltende arzneimittelformulierungen
JP5165244B2 (ja) * 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物
NZ563596A (en) 2005-05-02 2011-01-28 Boehringer Ingelheim Int Crystalline form of tiotropium bromide anhydrate
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
CN104306361A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种含噻托溴铵的吸入性溶液
CN111374963A (zh) * 2018-12-31 2020-07-07 天津药业研究院有限公司 一种用于吸入的噻托铵溶液剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
EA200300482A1 (ru) 2003-12-25
MXPA03003742A (es) 2004-10-15
ECSP034541A (es) 2003-05-26
JP4344135B2 (ja) 2009-10-14
BG107727A (bg) 2004-11-30
NZ526023A (en) 2005-05-27
EE200300203A (et) 2003-10-15
AU2002221738B2 (en) 2007-01-11
NO20031911L (no) 2003-04-29
EP1333819A2 (de) 2003-08-13
MY138940A (en) 2009-08-28
TWI293885B (en) 2008-03-01
IL155538A0 (en) 2003-11-23
UY26989A1 (es) 2002-06-20
HUP0301378A3 (en) 2005-12-28
PT1333819E (pt) 2007-10-29
CN101292964A (zh) 2008-10-29
WO2002036104A2 (de) 2002-05-10
DE10152521A1 (de) 2002-07-11
CZ20031486A3 (cs) 2003-08-13
PL360405A1 (en) 2004-09-06
MEP40408A (en) 2011-02-10
AR038764A1 (es) 2005-01-26
ME00244B (me) 2011-05-10
AU2173802A (en) 2002-05-15
SI1333819T1 (sl) 2007-12-31
BRPI0115076B8 (pt) 2021-05-25
SK5272003A3 (en) 2003-10-07
BR0115076A (pt) 2003-07-29
CA2426074C (en) 2008-12-23
DK1333819T3 (da) 2007-12-03
CA2426074A1 (en) 2002-05-10
ES2294045T3 (es) 2008-04-01
HU229411B1 (en) 2013-12-30
DE50113037D1 (de) 2007-10-31
YU33003A (sh) 2006-05-25
CN100396285C (zh) 2008-06-25
PL203316B1 (pl) 2009-09-30
RS50859B (sr) 2010-08-31
IL155538A (en) 2008-11-26
SK286027B6 (sk) 2008-01-07
EP1333819B1 (de) 2007-09-19
CY1107825T1 (el) 2013-06-19
EA007604B1 (ru) 2006-12-29
CZ300794B6 (cs) 2009-08-12
BRPI0115076B1 (pt) 2016-07-26
HRP20030338B1 (en) 2011-09-30
JP2004512357A (ja) 2004-04-22
KR100853107B1 (ko) 2008-08-21
HK1060524A1 (en) 2004-08-13
EP1837021A3 (de) 2008-03-19
ATE373473T1 (de) 2007-10-15
NO332519B1 (no) 2012-10-08
EP1837021A2 (de) 2007-09-26
HRP20030338A2 (en) 2005-04-30
SA01220482B1 (ar) 2007-07-31
KR20030060926A (ko) 2003-07-16
CN1473038A (zh) 2004-02-04
NO20031911D0 (no) 2003-04-29
UA78690C2 (uk) 2007-04-25
EE05314B1 (et) 2010-08-16
BG66315B1 (bg) 2013-04-30
ZA200302922B (en) 2004-04-22
PE20030092A1 (es) 2003-03-24
WO2002036104A3 (de) 2002-08-01

Similar Documents

Publication Publication Date Title
US11116724B2 (en) Methotrexate composition
UA71585C2 (uk) Стійкий при зберіганні концентрат біологічно активної речовини формотеролу
KR970704472A (ko) 수성 리스페리돈 제제(aqueous risperidone formulations)
JPS62283927A (ja) 経鼻投与用水性ステロイド製剤
CZ20011362A3 (cs) Skladovatelný koncentrát účinné látky s formoterolem
JP2009518305A (ja) ５，１０メチレンテトラヒドロ葉酸の安定な薬学的組成物
JP2003505419A (ja) ケトチフェンを含む眼用組成物
HUP0301377A2 (hu) Tiotropiumsót tartalmazó inhalációs oldatformájú kombinációs gyógyszerkészítmény
KR20010012521A (ko) 방부 조성물
HUP0301378A2 (hu) Tiotropiumsót tartalmazó inhalációs oldatformájú gyógyszerkészítmény
US5422102A (en) Antiinflammatory and analgesic gel preparation
HUP0203121A2 (hu) Szubsztituált benzimidazolokat tartalmazó gyógyszerkészítmény és alkalmazása
BRPI0409878A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
DK2662093T3 (en) tobramycin
WO2005112909A1 (ja) 消炎鎮痛外用水性液剤
JP2001247446A (ja) 深層水配合洗浄薬
JPH075456B2 (ja) 点眼液
JP5500162B2 (ja) 点眼剤
JPH0717863A (ja) プラノプロフェン点眼液
JP2003502361A5 (hu)
JPH10236951A (ja) プラノプロフェン配合点眼剤
JPH0536412B2 (hu)
WO2021216450A8 (en) Opioid antagonist formulations
JP4961671B2 (ja) 点眼剤
JP5111372B2 (ja) 安定および保存化ケトチフェン眼用組成物

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): BELICZAY LASZLO, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: RATHONYI ZOLTAN S.B.G. & K. BUDAPESTI NEMZETKO, HU

FH92 Termination of representative

Representative=s name: BELICZAY LASZLO, S.B.G. & K. SZABADALMI UEGYVI, HU